Company Overview and News

 
Skyharbour Option Partner Azincourt Energy to Drill East Preston Uranium Project, Athabasca Basin

2018-08-22 globenewswire
VANCOUVER, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce its option partner Azincourt Energy (TSX.V: AAZ, OTC: AZURF) (“Azincourt”) has provided an update regarding its upcoming winter work program at the East Preston uranium project, located in the southwestern Athabasca Basin, Saskatchewan, Canada.
SYHBF NXE DNN NXGEF FCUUF AZURF DML FCU SYH

 
Skyharbour Completes 100% Earn-In and Announces Plans for Upcoming Summer Drill Program at Moore Uranium Project; Raises Additional $450,000 from Warrant Exercise

2018-08-21 globenewswire
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce plans for its upcoming summer/fall 2018 diamond drill program to commence shortly and that it has now completed the 100% earn-in of its flagship, high grade Moore Uranium Project well ahead of schedule. In addition, 1,159,175 warrants have been exercised recently raising an additional CAD $449,884 in net proceeds for the Company.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

 
Skyharbour Grants Stock Options

2018-08-17 globenewswire
VANCOUVER, British Columbia, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) announces that it has granted incentive stock options (the “Options”) to certain directors, officers, management, company employees and consultants entitling them to purchase up to an aggregate of 1,500,000 common shares in the capital of the Company, subject to the policies of the TSX Venture Exchange.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

 
Cypress Development Corp. Is A Very Promising Lithium Clay Developer In The USA

2018-08-16 seekingalpha
Risk revolves around producing lithium from clay economically at scale; however several competitors are also moving forward in this direction.
GSC ABX CYP DNN CYDVF DML ABX

 
Skyharbour Closes Non-Brokered Private Placement of $2.6 Million

2018-08-02 globenewswire
VANCOUVER, British Columbia, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the closing of a non-brokered private placement for aggregate gross proceeds of approx. CAD $2.6 million (the “Financing”). The Company now has over $3.2 million in the treasury and is fully funded for upcoming diamond drill programs at its flagship Moore Uranium project located on the southeast side of the Athabasca Basin proximal to regional infrastructure, as well as nearby development projects and producing mines.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

 
Skyharbour Increases its Private Placement of Common and Flow-Through Shares

2018-07-31 globenewswire
VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) announces that due to strong interest the Company has increased its non-brokered private placement financing to aggregate gross proceeds of approx. CAD $2.5 million. The Company has increased its placement from 3,250,000 units of the Company (the “Units”) to 3,600,000 Units at a price of CAD $0.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

 
Skyharbour Increases its Private Placement of Common and Flow-Through Shares

2018-07-27 globenewswire
VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) announces that due to strong interest the Company has increased its non-brokered private placement financing to aggregate gross proceeds of approx. CAD $2 million. The Company has increased its placement from 2,000,000 units of the Company (the “Units”) to 3,250,000 Units at a price of CAD $0.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

 
Skyharbour Announces a Private Placement of Common and Flow-Through Shares

2018-07-17 globenewswire
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) announces that it has arranged a non-brokered private placement of up to 2,000,000 units of the Company (the “Units”) at a price of CAD $0.40 each and up to 1,500,000 flow-through Units (the “FT Units”) at a price of CAD $0.45 each, for combined total gross proceeds of up to CAD $1,475,000.
SYHBF NXE DNN NXGEF FCUUF DML FCU SYH

69
Uranium Mining: The Competitive Landscape

2018-06-25 seekingalpha - 1
The operators in the Athabasca Basin, Canada, enjoy the highest-grade uranium deposits and have a geological edge over other uranium districts.
PALAY PEN RIO LAM BLT AZZ TOEYF SYH PDN UEXCF PALAF NXE UEC EFR BMN LMRXF FSY DNN PWURF CVV RIO BBL GVXXF BHPLF FCU SYHBF DYLLF RIO NXGEF BKY ISENF CVVUF WSTRF RTPPF FOSYF TOE RTNTF CCJ UUUU DYL PENMF UWEFF KVLQF TGRUF MGAFF PDN BHPBF FCUUF EU URG DML BKY MGA PUMGF BHP BNNLF 9888 BHP LAM

12
Denison Reports High-Grade Uranium Intercepts Northeast of the Gryphon Deposit

2018-04-18 globenewswire
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Denison Mines Corp. (“Denison” or the “Company”) (TSX:DML) (NYSE MKT:DNN) (NYSE American:DNN) is pleased to report the discovery of high-grade uranium mineralization 600 metres and 1 kilometre to the northeast of the Gryphon uranium deposit, on the Company’s 63.3% owned Wheeler River project, in northern Saskatchewan. The winter drilling program is now complete, resulting in a total of 21,153 metres drilled in 29 diamond drill holes.
DNN U CCJ DML URPTF

2
Denison Announces Filing of Annual Report on Form 40-F

2018-03-28 globenewswire
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Denison Mines Corp. (“Denison” or the “Company”) (TSX:DML) (NYSE American:DNN) is pleased to announce that it has filed its 2017 annual report on Form 40-F with the U.S. Securities and Exchange Commission ("SEC"). Denison’s Form 40-F incorporates by reference the management discussion and analysis and audited financial statements of the Corporation for the year ended December 31, 2017, as furnished to the Commission on Denison’s Form 6-K dated March 9, 2018.
DNN U DML URPTF

2
Denison Announces Increase in Mineral Resources Estimated for the Midwest Uranium Project

2018-03-27 globenewswire
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Denison Mines Corp. (“Denison” or the “Company”) (TSX:DML) (NYSE MKT:DNN) (NYSE American:DNN) is pleased to announce an increase in the mineral resources estimated for the Midwest Project, located in the eastern Athabasca Basin, northern Saskatchewan, Canada. The Project is host to the high-grade Midwest Main and Midwest A uranium deposits which lie along strike and within six kilometres of the J Zone deposit and Huskie discovery on Denison’s 64.
DNN U DML URPTF

4
Denison Announces Filing of Technical Report for Wheeler River

2018-03-16 marketwired - 2
TORONTO, ONTARIO--(Marketwired - March 16, 2018) - Denison Mines Corp. ("Denison" or the "Company") (TSX:DML)(NYSE MKT:DNN)(NYSE American:DNN) today announces that it filed a technical report under Canadian Securities Administrators' National Instrument 43-101 Standard of Disclosure for Mineral Projects for its 63.3% owned Wheeler River Project in Saskatchewan titled "Technical Report with an Updated Mineral Resource Estimate for the Wheeler River Property, Northern Saskatchewan, Canada" dated March 15, 2018 with an effective date of March 9, 2018.
DNN U DML URPTF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TSX:DML / Denison Mines Corp. on message board site Silicon Investor.

NDM/NDMLF Northern Dynasty NDM/NDMLF Northern Dynasty NDM/NDMLF Northern Dynasty Federal-Mogul Corporation (FDMLQ) Federal-Mogul Corporation (FDMLQ) Federal-Mogul Corporation (FDMLQ)
Donner Minerals (DML.V) Donner Minerals (DML.V) Donner Minerals (DML.V)